Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Health care product distributor Henry Schein has redoubled its effort to provide in-kind donations and grants to disaster-stricken areas, as well as to work with NGOs to proactively supply ...

Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks ...

KKR to invest $250M in Henry Schein, increasing stake to 12%, with an option to reach 14.9%. Henry Schein raises share buyback program by $500M and expects moderate revenue and EPS growth in 2025.

MELVILLE, N.Y., January 29, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) ("Henry Schein" or the "Company"), the world’s largest provider of health care ...

Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...